schizophrenia

Quetiapine is a dibenzothiazepine second generation antipsychotic acts as serotonin-dopamine antagonist  (SDA), available in tablet dosage form in the strength of  25, 100 & 200 mg XR. It is developed  by Zeneca and approved by FDA in…

Antipsychotic drugs have been used in patients with chronic schizophrenia for a very long time, but the relative effectiveness has not been explored even with widespread use. Particularly, there exists very little literature describing the…

Just like other mental illnesses recovery from schizophrenia is widely discussed and this made the baseline for this study with focus on assessing the relationship between personal recovery and prediction variables.  Particularly, the study…

Oral antipsychotic therapy has been characterized by nonadherence and partial adherence in patients with schizophrenia. The electronic Schizophrenia Treatment Adherence Registry (e-STAR) aimed at assessing outcomes of Risperidone…

A study on development of schizophrenia spectrum disorders (SSD) in patients diagnosed with substance-induced psychoses (SIP) was carried out on 18,478 Finnish inpatients. The primary aim of the study was to investigate the rate of SIP…

Patients with schizophrenia face a number of life-threatening conditions, but there exist a variety of predictors that can enhance the quality of life (QoL) as well as favorable long-term health outcomes. Some of the predictors include…

Comprehensive schizophrenia treatment is subject to a number of considerations, with the most important being enhanced work function. Although various studies have explored the factors influencing patients’ performance at work, little is…

Schizophrenia is a deliberating mental disorder that changes the way a person thinks, acts, expresses emotions, perceives reality and relates to others in the social context. Although it affects equally men and women but onset is later…